LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
6.92
+0.06 (0.87%)
At close: Sep 11, 2026, 4:00 PM EDT
6.99
+0.07 (1.01%)
After-hours: Sep 11, 2026, 7:30 PM EDT
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $65.2 million as of September 11, 2026. Its market cap has increased by 333.89% in one year.
Market Cap
65.20M
Enterprise Value
14.71M
1-Year Change
333.89%
Ranking
Category
Stock Price
$6.92
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $65.20M, a decrease of -87.64%. That is a compound annual growth rate of -29.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 65.20M | 118.38% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 67.72M |
| XBiotech | 66.77M |
| Alps Group | 66.56M |
| Dogwood Therapeutics | 65.95M |
| Spero Therapeutics | 65.81M |
| Gossamer Bio | 65.57M |
| Boundless Bio | 64.37M |
| Eloxx Pharmaceuticals | 63.57M |